What investor type does Sanofi fit best in FoxScore?

Sanofi shows a mixed profile: stability is strongest, but trend lags noticeably. Use the sub-scores as a radar, then decide based on the metrics whether the risk/return profile fits you.

How meaningful is the available history for Sanofi?

Sanofi currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for Sanofi

SAN.FR · As of: 02/17/2026

Basic information

Type: Stock

Region: Europe

Sector: Health Care

TER: –

History

Available history:15.0 years

Last tradingday:02/17/2026

Description & usage

Sanofi is a global pharmaceutical company focused on prescription medicines, vaccines and specialty therapies. Performance is often driven by pipeline progress, clinical readouts, regulatory approvals and successful product launches. At the same time, patent expiries, healthcare pricing pressure and regulatory decisions are key factors—pharma can look defensive, yet single events can still move the stock sharply.

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

Sanofi (SAN.FR) currently has a total score of 26 points, placing it in the weak range. The score is made up of Performance (17), Stability (49) and Trend (16). The profile is clearly uneven: Stability stands out while Trend lags.

Performance scores 17 points (very weak). Least weak metric: 5Y return at -4.9 %. Main drag: 10Y return at 1.1 %.

Stability scores 49 points (neutral). Best-ranked metric: max drawdown (10Y) at -37.2 %. Weaker metric: return/volatility ratio at -0.95. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 16 points (very weak). Trend signals are mostly negative right now. Least weak signal: Price is about 4.0 % below SMA50. Main drag: trend strength at -0.84. That often means the move is strong, but not perfectly steady.

Overall, the profile has a clear strength in Stability, while Trend is the main limiter. On a metric level, max drawdown (10Y) stands out, while trend strength is the main weak spot.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

weak

Scores

Metrics

FAQ

What investor type does Sanofi fit best in FoxScore?: Sanofi shows a mixed profile: stability is strongest, but trend lags noticeably. Use the sub-scores as a radar, then decide based on the metrics whether the risk/return profile fits you.
How meaningful is the available history for Sanofi?: Sanofi currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.